Citius Pharmaceuticals, Inc. (CTXR)
0.5316
-0.01
(-1.59%)
USD |
NASDAQ |
Oct 02, 16:00
0.5315
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Net Income (Quarterly) : -11.92M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.92M |
| March 31, 2026 | -28.11M |
| December 31, 2025 | -9.394M |
| September 30, 2025 | -8.744M |
| June 30, 2025 | -9.204M |
| March 31, 2025 | -11.51M |
| December 31, 2024 | -10.28M |
| September 30, 2024 | -11.08M |
| June 30, 2024 | -10.57M |
| March 31, 2024 | -8.544M |
| December 31, 2023 | -9.231M |
| September 30, 2023 | -9.944M |
| June 30, 2023 | -8.479M |
| March 31, 2023 | -10.53M |
| December 31, 2022 | -3.594M |
| September 30, 2022 | -7.991M |
| June 30, 2022 | -8.864M |
| March 31, 2022 | -7.561M |
| December 31, 2021 | -9.225M |
| September 30, 2021 | -4.961M |
| June 30, 2021 | -5.824M |
| March 31, 2021 | -4.122M |
| December 31, 2020 | -8.147M |
| September 30, 2020 | -4.121M |
| June 30, 2020 | -4.680M |
| Date | Value |
|---|---|
| March 31, 2020 | -4.425M |
| December 31, 2019 | -4.322M |
| September 30, 2019 | -3.650M |
| June 30, 2019 | -4.406M |
| March 31, 2019 | -3.632M |
| December 31, 2018 | -3.875M |
| September 30, 2018 | -2.847M |
| June 30, 2018 | -2.022M |
| March 31, 2018 | -4.422M |
| December 31, 2017 | -3.246M |
| September 30, 2017 | -3.043M |
| June 30, 2017 | -2.422M |
| March 31, 2017 | -2.743M |
| December 31, 2016 | -2.176M |
| September 30, 2016 | -2.590M |
| June 30, 2016 | -3.616M |
| March 31, 2016 | -0.8695M |
| December 31, 2015 | -1.221M |
| September 30, 2015 | -0.9083M |
| June 30, 2015 | -0.825M |
| March 31, 2015 | -0.3453M |
| December 31, 2014 | -0.8237M |
| June 30, 2014 | -0.0063M |
| March 31, 2014 | -0.01M |
| December 31, 2013 | -0.0004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.494M |
| Total Expenses (Quarterly) | 10.36M |
| EPS Diluted (Quarterly) | -0.3387 |
| Enterprise Value | 14.06M |
| Gross Profit Margin (Quarterly) | -48.09% |
| Profit Margin (Quarterly) | -797.9% |
| Earnings Yield | -397.0% |
| Normalized Earnings Yield | -397.01 |